Revenue performance remains erratic and non-core, with quarterly figures fluctuating between zero and $186.7K while SG&A expenses consistently exceed $9M per quarter.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Sales/Revenue | 141.7K | 92.49K | 667.13K | 0 | 0 | 10.23K | 23.45K | 15.39K | 19.72K | 43.25K | 13.32K | 63.61K | 492.13K | 791.78K | 0 | 0 |
| Revenue Growth % | -71.72% | -86.14% | - | - | -100% | -56.36% | 52.32% | -21.93% | -54.42% | 224.65% | -79.06% | -87.07% | -37.85% | - | - | - |
| Cost of Goods Sold | 151.97K | 151.92K | 401.44K | 24.92K | 14.66K | 245.81K | 129.94K | 182.17K | 126.22K | 208.84K | 218.25K | 163.15K | 446.61K | 448.83K | 0 | 0 |
| COGS % of Revenue | - | 164.26% | 60.17% | - | - | 2402.37% | 554.22% | 1183.45% | 640.18% | 482.83% | 1638.11% | 256.48% | 90.75% | 56.69% | - | - |
| Gross Profit | -10.26K | -59.43K | 265.69K | -24.92K | -14.66K | -235.58K | -106.5K | -166.78K | -107K | -166K | -205K | -99.54K | 45.52K | 342.95K | 0 | 0 |
| Gross Margin % | -7.24% | -64.26% | 39.83% | - | - | -2302.37% | -454.22% | -1083.45% | -542.71% | -383.79% | -1538.69% | -156.48% | 9.25% | 43.31% | - | - |
| Gross Profit Growth % | - | -122.37% | 1166.06% | -70.02% | 93.78% | -121.21% | 36.14% | -55.86% | 35.54% | 19.02% | -105.95% | -318.66% | -86.73% | - | - | - |
| Operating Expenses | 38.64M | 31.59M | 44.12M | 41.99M | 5.85M | 3.28M | 1.18M | 1.1M | 1.05M | 1.22M | 1.12M | 1.18M | 1.9M | 2.78M | 152.66K | 183.19K |
| OpEx % of Revenue | - | 34157.13% | 6613.98% | - | - | 32061.32% | 5011.75% | 7130.31% | 5340.84% | 2813.68% | 8391.5% | 1859.77% | 386.48% | 350.6% | - | - |
| Selling, General & Admin | 31.18M | 31.59M | 43.99M | 41.99M | 5.85M | 3.28M | 1.18M | 1.1M | 1.05M | 1.22M | 1.12M | 1.18M | 1.9M | 1.92M | 152.66K | 183.19K |
| SG&A % of Revenue | - | 34157.13% | 6593.24% | - | - | 32061.32% | 5011.75% | 7130.31% | 5340.84% | 2813.68% | 8391.5% | 1859.77% | 386.28% | 242.62% | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 2M | 0 | 138.41K | 0 | 0 | 0 | 0 | 0 | 0 | -1.54K | 0 | 20 | 216 | 835.39K | 0 | 0 |
| Operating Income | -38.65M | -31.65M | -43.86M | -42.02M | -5.86M | -3.52M | -1.28M | -1.26M | -1.16M | -1.38M | -1.32M | -1.28M | -1.86M | -2.41M | -153K | -183K |
| Operating Margin % | -27276.3% | -34221.39% | -6574.16% | - | - | -34363.68% | -5465.98% | -8213.76% | -5878.47% | -3197.47% | -9930.2% | -2016.98% | -377.14% | -304.76% | - | - |
| Operating Income Growth % | - | 27.83% | -4.38% | -616.88% | -66.69% | -174.36% | -1.36% | -9.09% | 16.2% | -4.54% | -3.12% | 30.87% | 23.08% | -1477.12% | 16.39% | - |
| EBITDA | -38.47M | -31.53M | -43.66M | -41.99M | -5.85M | -3.48M | -1.23M | -1.2M | -1.08M | -1.29M | -1.24M | -1.23M | -1.86M | -2.41M | -153K | 186 |
| EBITDA Margin % | -27147.12% | -34092.6% | -6544.39% | - | - | -33998.87% | -5262.25% | -7801.51% | -5496.32% | -2989.3% | -9277.15% | -1928.43% | -377.09% | -304.7% | - | - |
| EBITDA Growth % | 4.46% | 27.78% | -3.97% | -618.25% | -68.06% | -181.96% | -2.74% | -10.82% | 16.19% | -4.61% | -0.76% | 33.9% | 23.08% | -1476.84% | -82358.06% | - |
| D&A (Non-Cash Add-back) | 183.05K | 119.12K | 198.62K | 24.92K | 14.66K | 37.33K | 47.77K | 63.46K | 75.35K | 90.04K | 87K | 56.33K | 216 | 433 | 0 | 183.19K |
| EBIT | -38.63M | -31.65M | -43.86M | -41.99M | -6.06M | -3.77M | -1.12M | -1.33M | -1.16M | -1.38M | -1.27M | -715K | -2.57M | -2.41M | 0 | 0 |
| Net Interest Income | 159.69K | 0 | 416.01K | 0 | -155.81K | -253.6K | -427.31K | -755K | -689K | -507K | -472K | -1.16M | -828K | -22.64K | 0 | 0 |
| Interest Income | 335.02K | 0 | 416.01K | 0 | 0 | 0 | 0 | 754.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 175.33K | 0 | 0 | 0 | 155.81K | 253.6K | 427.31K | 754.75K | 689.34K | 506.56K | 472.06K | 1.16M | 827.61K | 22.64K | 0 | 0 |
| Other Income/Expense | 422.73K | -250.16K | -536.05K | 25.89K | -200.7K | -509.37K | -264.48K | -821.54K | -689K | -508K | -417K | -595K | -1.54M | -22.17K | 0 | 0 |
| Pretax Income | -38.23M | -31.9M | -44.39M | -41.99M | -6.06M | -4.03M | -1.55M | -2.09M | -1.85M | -1.89M | -1.74M | -1.88M | -3.4M | -2.44M | -153K | -183K |
| Pretax Margin % | -26977.98% | -34491.86% | -6654.51% | - | - | -39341.92% | -6594.02% | -13550.84% | -9378.17% | -4371.95% | -13060.12% | -2952.37% | -691.08% | -307.53% | - | - |
| Income Tax | -1.02M | 0 | 18.92K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.81K | 0 | 21.81K | -183K |
| Effective Tax Rate % | 2.67% | 0% | -0.04% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -0.82% | 0% | -14.25% | 100% |
| Net Income | -32.65M | -28.11M | -42.24M | -40.77M | -4.93M | -2.77M | -1.14M | -1.86M | -1.67M | -1.69M | -1.59M | -1.88M | -3.44M | -2.22M | -174K | 0 |
| Net Margin % | -23042.05% | -30392.79% | -6331.77% | - | - | -27094.98% | -4869.33% | -12096.91% | -8449.99% | -3909.56% | -11919.24% | -2952.37% | -698.39% | -280.25% | - | - |
| Net Income Growth % | 14.74% | 33.45% | -3.61% | -726.65% | -77.89% | -142.84% | 38.69% | -11.77% | 1.48% | -6.49% | 15.44% | 45.36% | -54.89% | -1175.29% | - | - |
| Net Income (Continuing) | -37.21M | -31.9M | -44.41M | -41.99M | -6.06M | -4.03M | -1.55M | -2.09M | -1.85M | -1.89M | -1.74M | -1.88M | -3.43M | -2.44M | -174K | 0 |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 7.3M | 578.76K | 753.46K | 427.3K | 1.11M | 1.55M | 1.98M | 1.45M | 1.37M | 1.39M | 1.33M | 131.05K | 0 | 409.96K | 0 | 0 |
| EPS (Diluted) | -1.20 | -1.54 | -2.91 | -4.11 | -1.00 | -0.75 | -0.67 | -1.74 | -5.67 | -15.00 | -60.00 | -600.00 | -10875.45 | -11150.12 | -937.97 | 0.00 |
| EPS Growth % | 35.78% | 47.08% | 29.2% | -311% | -33.33% | -11.94% | 61.49% | 69.31% | 62.2% | 75% | 90% | 94.48% | 2.46% | -1088.75% | - | - |
| EPS (Basic) | - | -1.54 | -2.91 | -4.11 | -1.00 | -0.75 | -0.67 | -1.74 | -5.67 | -16.54 | -60.00 | -580.59 | -10875.45 | -11150.12 | -937.97 | 0.00 |
| Diluted Shares Outstanding | 27.24M | 18.23M | 14.53M | 10.07M | 4.61M | 3.69M | 1.7M | 1.07M | 294.06K | 102.27K | 25.8K | 3.13K | 316 | 199 | 186 | 344 |
| Basic Shares Outstanding | 27.24M | 18.23M | 14.53M | 10.07M | 4.61M | 3.69M | 1.7M | 1.07M | 294.06K | 102.27K | 25.8K | 3.13K | 316 | 199 | 186 | 344 |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pre-revenue development execution risk
According to recent financial disclosures, ATLX's top-line performance remains erratic, with quarterly revenue fluctuating between zero and $186.7K, confirming that current income is derived from legacy industrial mineral sales rather than the company's primary lithium development objectives in the Minas Gerais region.
The extreme volatility in revenue, including periods of zero reported income, underscores the lack of a sustainable commercial engine. Investors should interpret these figures as incidental to the company's long-term valuation, as they do not represent the future spodumene concentrate production profile.
As reported in quarterly filings, the company maintains a significant SG&A burden, with expenses frequently exceeding $9M per quarter, which highlights the substantial corporate and administrative costs required to sustain exploration activities while the Neves Project remains in the pre-production development phase.
The persistent high level of SG&A relative to negligible revenue suggests a heavy corporate burn rate that is typical of junior miners. This cost structure warrants close monitoring, as it directly impacts the company's runway before it can achieve a Final Investment Decision.
Based on the provided income statement data, Atlas Lithium has consistently utilized stock-based compensation, with figures reaching as high as $7.9M in a single quarter, which significantly complicates the assessment of true operational losses and creates ongoing dilution risks for existing equity holders.
The reliance on equity-based incentives during a pre-revenue phase suggests management is prioritizing cash preservation, yet it obscures the true economic cost of operations. Analysts should adjust for these non-cash charges to better understand the underlying cash burn rate of the business.
Analysis of the income statement reveals that gross margins have been highly inconsistent, swinging from positive 51.8% to negative 57.3% in recent periods, which suggests that the company's current cost-to-revenue profile is not yet optimized for stable, long-term spodumene production.
The lack of consistent gross profitability indicates that the company's legacy operations are not a reliable proxy for future lithium margins. Investors should be wary of assuming that current cost structures will scale efficiently once the modular processing plant is commissioned.
Quick answers to the most common questions about buying ATLX stock.
For fiscal year 2025, Atlas Lithium Corporation (ATLX) reported total revenue of $0.1M.
Atlas Lithium Corporation (ATLX) reported a net loss of $28.1M for the fiscal year ending 2025.
Atlas Lithium Corporation (ATLX) reported an operating income of $-31.7M, resulting in an operating profit margin of -34221.4%. This margin reflects the operational efficiency of the business before interest and taxes.
Atlas Lithium Corporation (ATLX) generated $-0.1M in gross profit for the year, representing a gross profit margin of -64.3%. This demonstrates the company's core pricing power and production efficiency.